| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 02/20/2003 | WO2003014312A2 Alteration of acyltransferase domain substrate specificity |
| 02/20/2003 | WO2003014311A2 Methods for altering polyketide synthase genes |
| 02/20/2003 | WO2003014294A2 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | WO2003014161A2 Antigen binding domains from fish |
| 02/20/2003 | WO2003013565A1 Functional materials, sod agonists, hypotensives and thrombolytics, process for producing the same and microbial strains to be used therein |
| 02/20/2003 | WO2003013431A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/20/2003 | WO2003013426A2 Multivalent synthetic vaccine for cancer |
| 02/20/2003 | WO2003000851A3 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 02/20/2003 | WO2002098900A3 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 02/20/2003 | WO2002098369A3 Mutant forms of cholera holotoxin as an adjuvant |
| 02/20/2003 | WO2002094980A3 Phytocystatin |
| 02/20/2003 | WO2002094874A3 Internalisation of virus into cells |
| 02/20/2003 | WO2002086085A3 Human timp-1 antibodies |
| 02/20/2003 | WO2002070683A3 Biological compositions for solid waste treatment |
| 02/20/2003 | WO2002068645A8 Compositions and methods relating to breast specific genes and proteins |
| 02/20/2003 | WO2002068607A3 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 02/20/2003 | WO2002068605A3 Non-oligomerizing tandem fluorescent proteins |
| 02/20/2003 | WO2002066505A3 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof |
| 02/20/2003 | WO2002062298A3 Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
| 02/20/2003 | WO2002052012A8 Sugar beet genes involved in stress tolerance |
| 02/20/2003 | WO2002051978A3 Yeasts transformed by genes enhancing their cold stress tolerance |
| 02/20/2003 | WO2002046441A3 Targets for herbicides and transgenic plants resistant to said herbicides |
| 02/20/2003 | WO2002045738A3 Vaccine composition containing transforming growth factor alpha |
| 02/20/2003 | WO2002029075A9 Multiple inducible gene regulation system |
| 02/20/2003 | WO2002026950A3 Transferases |
| 02/20/2003 | WO2002012530A3 3-hydroxycarboxylic acid production and use in branched polymers |
| 02/20/2003 | US20030036646 Uncoupling protein polynucleotides, polypeptides, and antibodies |
| 02/20/2003 | US20030036644 Bacterial superantigen vaccines |
| 02/20/2003 | US20030036639 Immunizing compositions and methods of use |
| 02/20/2003 | US20030036634 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036633 DNA encoding bradykinin B1 receptor |
| 02/20/2003 | US20030036631 Protein for use in the treatment of asthma, leukemia, or other allergic or inflammatory defects |
| 02/20/2003 | US20030036630 Nucleotide sequences for use in human therapeutics and diagnostics |
| 02/20/2003 | US20030036511 Preparation of pure isoforms using TSK sulfopropyl cation exchange chromatography and reverse phase high performance liquid chromatography. |
| 02/20/2003 | US20030036510 Novel human cell division cycle proteins |
| 02/20/2003 | US20030036198 Novel DNA cloning method |
| 02/20/2003 | US20030036197 Recombinant constructs and their use in reducing gene expression |
| 02/20/2003 | US20030036187 Genetically engineered bacteria for use in the biodegradation of oil |
| 02/20/2003 | US20030036186 Process for the preparation of cell beads BOD sensor useful for instant BOD estimation |
| 02/20/2003 | US20030036185 Novel amino acid sequences for human kidney cadherin-like polypeptides |
| 02/20/2003 | US20030036184 Polypeptides exhibiting PDE7 activity and their use for selecting compounds which inhibit PDE 7 enzyme activity |
| 02/20/2003 | US20030036178 Long wavelength engineered fluorescent proteins |
| 02/20/2003 | US20030036177 Single colonies of myxobacteria cells |
| 02/20/2003 | US20030036176 Directed genetic engineering of xanthomonas campestris |
| 02/20/2003 | US20030036173 Controlling gene expression in living cells |
| 02/20/2003 | US20030036172 Polypeptide for use in the treatment of cancerous, angiogenesis, inflammatory shock and autoimmune diseases |
| 02/20/2003 | US20030036171 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 02/20/2003 | US20030036170 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 02/20/2003 | US20030036168 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects |
| 02/20/2003 | US20030036167 Protease proteins that are related to the choriolytic hatching protease subfamily, recombinant DNA molecules, and protein production. |
| 02/20/2003 | US20030036112 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders |
| 02/20/2003 | US20030036110 Isolation of viral envelope proteins; obtain cells transform with vector containing viral protein, propagate cell, lyse cells, recover envelope proteins |
| 02/20/2003 | US20030036105 Antigen for use in the diagnosis of nematode infections |
| 02/20/2003 | US20030036092 Directed evolution of enzymes and antibodies |
| 02/20/2003 | US20030036075 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders |
| 02/20/2003 | US20030036051 Methods of screening for antagonists and agonists of polypeptides having kinase functions |
| 02/20/2003 | US20030036050 Recovering enzyme mutant of preferential activity; obtain mutants, display mutants on solid support, monitor structure and activity of mutant |
| 02/20/2003 | US20030035860 Novel lactic acid bacteria, fermented seasoning liquid containing the same, and a method for producing bread |
| 02/20/2003 | US20030035843 Method for processing and preserving collagen-based tissues for transplantation |
| 02/20/2003 | US20030035822 Compositions and methods for enhancing fiber digestion |
| 02/20/2003 | US20030035816 Soluble ctla4 mutant molecules and uses thereof |
| 02/20/2003 | US20030035798 Prevention infections; such as colds, influenza |
| 02/20/2003 | US20030035792 Recombinant MVA virus, and the use thereof |
| 02/20/2003 | CA2763913A1 Antigen binding domains |
| 02/20/2003 | CA2759765A1 Control of development of biofilms in industrial process water |
| 02/20/2003 | CA2457448A1 Human smooth muscle myosin heavy chain |
| 02/20/2003 | CA2456786A1 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 02/20/2003 | CA2456719A1 Chimeric proteins comprising a haem domain of a mammalian or plant cytochrome p450 and a scaffold-reductase domain from p450 bm3 of bacillus megaterium and uses thereof |
| 02/20/2003 | CA2456416A1 Coryneform bacteria which produce chemical compounds ii |
| 02/20/2003 | CA2456369A1 Proteins associated with cell growth, differentiation, and death |
| 02/20/2003 | CA2456222A1 Method for producing a marker-free mutated target organism and plasmid vectors suitable for the same |
| 02/20/2003 | CA2454910A1 Erythrocytic cells and method for preserving cells |
| 02/20/2003 | CA2453995A1 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | CA2453327A1 Stress-associated genetic products from ashbya gossypii |
| 02/20/2003 | CA2453248A1 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/20/2003 | CA2451919A1 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | CA2450780A1 Novel recombinant gene expression method by stop codon suppression |
| 02/19/2003 | EP1284286A1 Alpha-isomaltosyltransferase, process for producing the same and use thereof |
| 02/19/2003 | EP1284284A2 Cell culture model for arteriosclerosis |
| 02/19/2003 | EP1283888A2 Fructosyltransferases (inulosucrase and levansucrase) from lactobacillus reuteri |
| 02/19/2003 | EP1283887A1 Chimeric arterivirus-like particles |
| 02/19/2003 | EP1283886A2 Intracellular signaling proteins |
| 02/19/2003 | EP1283885A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/19/2003 | EP1283884A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 02/19/2003 | EP1283882A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 02/19/2003 | EP1283878A2 Receptor-based interaction trap |
| 02/19/2003 | EP1283876A2 Beta-galactosidase isolated from bifidobacterium |
| 02/19/2003 | EP1283875A1 Improved nucleic acid modifying enzymes |
| 02/19/2003 | EP1283874A2 Novel deoxynucleoside kinase enzyme variants |
| 02/19/2003 | EP1283870A1 Novel cell systems having specific interaction of peptide binding pairs |
| 02/19/2003 | EP1283868A2 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof |
| 02/19/2003 | EP1283849A2 Human receptor proteins; related reagents and methods |
| 02/19/2003 | EP1283848A2 Protein complexes and assays for screening anti-cancer agents |
| 02/19/2003 | EP1283721A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/19/2003 | EP1283719A2 Apoptotic agents |
| 02/19/2003 | EP1283714A1 Use of lactobacillus casei in immunostimulatory peptides |
| 02/19/2003 | EP1283676A2 A bioinsecticide formulation consisting of bacillus thuringiensis var israelensis, and its concerning manufacture proceedings |
| 02/19/2003 | EP0726960B1 Microbial strains producing sphingolipid bases |
| 02/19/2003 | CN1398299A BZIP type transcripton factors regulating expression of rice storage protein |
| 02/19/2003 | CN1398298A Non-endogenous, constitutively activated human G protein-coupled receptors |